Convatec Group (CTEC)

Sector:

Health Care

Index:

FTSE 100

256.80p
   
  • Change Today:
    -1.40p
  • 52 Week High: 275.60
  • 52 Week Low: 213.40
  • Currency: UK Pounds
  • Shares Issued: 2,049.79m
  • Volume: 8,557,789
  • Market Cap: £5,264m
  • RiskGrade: 96

CTEC Overview

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. Its products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. Based in Reading, it employs over 9,000 people in more than 100 countries.
Competitors: Consort Medical

Key Personnel

Chairman: John McAdam
CEO: Karim Bitar
CFO: Jonny Mason
Independent Non-Executive Director: Kimberly Lody
Independent Non-Executive Director: Heather Mason
Independent Non-Executive Director: Sharon O'Keefe
Independent Non-Executive Director: Constantin Coussios
Independent Non-Executive Director: Brian May
Senior Independent Non-Executive Director: Margaret Ewing
Non-Executive Dir:

Contact Details

Address: 7th Floor, 20 Eastbourne Terrace, London, United Kingdom, W2 6LG
Phone: +44 (0) 118 952 8100
Website: http://www.convatecgroup.com

Listings

Sector: Health Care(LSE)
Index: FTSE 100, FTSE 350, FTSE All-Share
ISIN: GB00BD3VFW73

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

CTEC Market Data

Currency UK Pounds
Share Price 256.80p
Change Today -1.40p
% Change -0.54 %
52 Week High 275.60
52 Week Low 213.40
Volume 8,557,789
Shares Issued 2,049.79m
Market Cap £5,264m
RiskGrade 96

CTEC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
98.16% below the market average98.16% below the market average98.16% below the market average98.16% below the market average98.16% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
57.78% above the market average57.78% above the market average57.78% above the market average57.78% above the market average57.78% above the market average
83.78% above the sector average83.78% above the sector average83.78% above the sector average83.78% above the sector average83.78% above the sector average
Income
84.72% below the market average84.72% below the market average84.72% below the market average84.72% below the market average84.72% below the market average
25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average
Growth
37.46% above the market average37.46% above the market average37.46% above the market average37.46% above the market average37.46% above the market average
29.41% below the sector average29.41% below the sector average29.41% below the sector average29.41% below the sector average29.41% below the sector average

What The Brokers Say

Strong Buy 7
Buy 9
Neutral 3
Sell 0
Strong Sell 0
Total 19
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CTEC Dividends

  Latest Previous
  Final Interim
Ex-Div 17-Apr-25 22-Aug-24
Paid 29-May-25 04-Oct-24
Amount 4.59¢ 1.82¢

Trades for 25-Apr-2025

Time Volume / Share Price
16:44 11,980 @ 257.27p
16:36 231 @ 256.80p
16:36 7,211 @ 256.80p
16:35 657,925 @ 256.80p
16:35 3,819 @ 256.80p

CTEC Key Personnel

CEO Karim Bitar
Chair John McAdam
CFO Jonny Mason

Top of Page